Photoset reblogged from "you two really are brothers" with 3,442 notes
This is the End.
My second tribute to the S8 FInale. Yeah, yeah, the angels falling scene again… ^^;;
Photoshop CS6
Source: petite-madame
Photo reblogged from so? with 1,551 notes
holmes and watson pieces side-by-side as requested by anon :)
thanks!
Source: ignify
Link reblogged from Current TV with 32 notes
Republicans Altered Benghazi Emails, CBS News Report Claims →
Scandalous.
Quelle surprise.
Source: robot-heart-politics
Photo reblogged from Mental Alchemy with 123 notes
Martin Buber said that an animal’s eyes have the power to speak a great language. He was fine. This little guy’s eyes are definitely saying “he who climbeth this tree shall invite my wrath upon himself”
n animal’s eyes have the power to speak a great language.”
― Martin Buber
Source: littlepawz
Video reblogged from astolat with 40 notes
Song: Einstein on the Beach (For an Eggman) by Counting Crows
Fandom: Person of InterestSummary: Humpty Dumpty had a great fall.
Password to view: haroldcrow
Streaming and download links LJ and Dreamwidth.
*sniffles for poor eggman Harold* Watch watch! <3
Source: giandujakiss
Link reblogged from here’s luck with 125 notes
A single company owns the exclusive patent on the BRCA 1 and 2 mutations—and jacks up the price for a $200 genetic test for breast cancer risk to $3,000, just because they can. →
In the wake of Angelina Jolie’s well-intention exhortation for “every woman” to explore their risk of breast cancer, one company stands to make a staggering profit….The big winner on Tuesday was not women’s health; it was Myriad Genetics, the company that has held the exclusive patent on the BRCA 1 and 2 mutations since the 1990s. Because, in part, of Jolie’s well-intentioned but ambiguously worded exhortation for “every woman” to explore her risk, Myriad may well see a surge in business. And business is already booming: according to Karuna Jaggar, the Executive Director of Breast Cancer Action, “Myriad Genetics’ claim on our very DNA creates a profitable corporate monopoly for them, generating approximately half a billion dollars a year in revenue. In the last fiscal quarter alone, Myriad made $126 million off genetic testing for breast cancer—a full 85 percent of their total revenue.” Although the BRCA test could be easily performed by hundreds of US laboratories for as little as $200, Myriad’s patent prevents these more affordable tests from being performed.
Source: thenationmagazine
Link reblogged from Current TV with 213 notes
CONFIRMED: GOP Sources Altered Benghazi E-Mails To Suggest A Cover-Up →
Source: think-progress
Page 1 of 439